In a related context, TTLL10-AS1, an autophagy-related long noncoding RNA, is part of a prognostic signature for ovarian cancer; its expression is associated with immune cell infiltration, PD-L1 levels, and chemotherapy sensitivity, ultimately influencing clinical outcomes [48]. This evidence concerns the gene TTLL10 and ovarian carcinoma.